5th Scientific Drug Delivery Conference
Live Conference on FORMULATION DEVELOPMENT and TECHNOLOGIESFeb. 07th, 2024 This 1-day conference is an excellent opportunity for R&D Managers, Technology Experts and Business Development Managers who have specific interest in up-to-date formulation technologies and their special aspects in formulation and analytical development.
What are the benefits of this Drug Delivery Conference?
International experts and guest speakers from industry and academia will be presenting relevant topics as well as the most current case studies.
The agenda will provide room for expert discussions and exchanging know-how. Participants will also be able to directly apply their learnings from this symposium to their daily work. For any questions, please contact ddcffm@losan.de
View our AGENDA 2024
DDC 2024 conference
Wednesday, 7th of February 2024
9:30
Registration & Welcome Coffee
10:00
Welcome & Introduction
Dr. Jens Morgenthaler, General Manager Losan Pharma GmbH,
Dr. François Boutignon, APTYS Pharmaceuticals
10:20
„QbCon – a new drying technology for sensitive drugs“
Dr. Robin Meier, L.B. Bohle Maschinen und Verfahren GmbH
10:50
„The roadmap to ivivc for ASD formulations“
Prof. Thomas Rades, Prof. Anette Muellertz, University of Copenhagen
11:20
Coffee Break
11:40
„Amorphous solid dispersions for PROTAC molecules“
Dr. Meike Harms, Merck Healthcare KGaA
12:10
„Wet ball milling: a toolbox for various applications to improve bioavailability“
Dr. Wolfgang Mohr / Dr. Matthias Rischer, Losan Pharma GmbH
12:40
Lunch
14:00
„3D printing – from development to GMP“
Dr. Anja Stulz / Dr. Ansgar Bögershausen, Losan Pharma GmbH
14:30
„Development of in vivo relevant QC dissolution methods“
Dr. Jochen Scher, Boehringer Ingelheim Pharma GmbH & Co. KG
15:00
Coffee Break
15:20
„Nanoformulation for enhanced drug delivery and better patient compliance“
Dr. Michael Black, Beneo GmbH
15:50
„Microfluidic nanoparticulate encapsulation method for novel drug substances“
Dr. Johannes Büscher, University of Saarland / Boehringer Ingelheim Pharma GmbH & Co. KG
16:20
Summary and Apéro
Dr. Jens Morgenthaler, General Manager Losan Pharma GmbH
Overview Losan DDC 2024
Date
February 07th, 2024
9:30 – 16:45
Participation fee
300 €
live conference
Frankfurt City, Flemings‘ Select Hotel
Symposium language
English
Chairman
Dr. François Boutignon, President & CEO APTYS Pharmaceuticals
Co Chairman
Dr. Matthias Rischer, Losan Pharma GmbH
Registration
Registration is closed
